While many taxpayers have already received their refunds, a few are still waiting for the amount to reach their bank accounts ...

Income tax refunds are now processed faster, but delays can occur. Taxpayers can track their refund status on the e-Filing portal or NSDL/TIN for older refunds. Potential delays stem from outstanding ...

Investing.com - Artiva Biotherapeutics (NASDAQ:ARTV), currently trading at $2.77 and showing strong analyst support with a consensus "Strong Buy" rating, has prioritized refractory rheumatoid ...

Enterome has received fast track designation from the US Food and Drug Administration for its lead OncoMimics immunotherapy EO2463, targeting follicular lymphoma in the low tumour burden ...

Rubicon Research IPO allotment status check: Applicant can check their Rubicon Research IPO allotment status online by logging in to the BSE website or the official registrar's website, MUFG Intime ...

INDIANAPOLIS — A new Indiana poll from a nonprofit organization found that more than half of polled voters believe the state is on the wrong track politically. According to a news release from ...

Some Americans are eligible to recieve inflation refund checks and NJ residents could get ANCHOR rebates in October, but what about a fourth stimulus check in 2025 from the IRS or the tariff rebate?

Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap stocks to buy for the next 5 years. On October 2, Bristol Myers Squibb announced a development in its Alzheimer’s program: its experimental ...

Inflation refund checks and ANCHOR checks are on the way for some Americans in October, but what about a fourth stimulus check in 2025 or the tariff rebate? Here's how to track the status of your ...

Seshaasai Technologies IPO allotment: Following a stellar demand for the Seshaasai Technologies' initial public offering (IPO), investor focus has now shifted to its allotment. Seshaasai Technologies ...

Alnodesertib, combined with irinotecan, targets ATM-negative metastatic colorectal cancer, showing promise in the STELLA study with favorable safety and clinical activity. The FDA's fast track ...